Loading...
6038

LBX Pharmacy Chain Joint Stock CompanySHSE:603883 Stock Report

Market Cap CN¥12.7b
Share Price
CN¥16.74
My Fair Value
CN¥22.27
24.8% undervalued intrinsic discount
1Y15.9%
7D-2.6%
Portfolio Value
View

LBX Pharmacy Chain Joint Stock Company

SHSE:603883 Stock Report

Market Cap: CN¥12.7b

603883 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

LBX Pharmacy Chain Joint Stock Company Competitors

Price History & Performance

Summary of share price highs, lows and changes for LBX Pharmacy Chain
Historical stock prices
Current Share PriceCN¥16.74
52 Week HighCN¥22.97
52 Week LowCN¥13.60
Beta0.67
1 Month Change-9.56%
3 Month Change-20.48%
1 Year Change15.93%
3 Year Change-30.76%
5 Year Change-65.13%
Change since IPO67.61%

Recent News & Updates

Recent updates

Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Dec 24
Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

Nov 06
We Think You Can Look Beyond LBX Pharmacy Chain's (SHSE:603883) Lackluster Earnings

LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Sep 06
LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Right But Growth Is Lacking After Shares Rocket 30%

Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Sep 02
Is LBX Pharmacy Chain (SHSE:603883) Using Too Much Debt?

Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Jul 03
Take Care Before Jumping Onto LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Even Though It's 30% Cheaper

Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

Jun 08
Here's Why We Think LBX Pharmacy Chain (SHSE:603883) Is Well Worth Watching

LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

May 21
LBX Pharmacy Chain (SHSE:603883) Seems To Use Debt Quite Sensibly

There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Apr 22
There Is A Reason LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Price Is Undemanding

Shareholder Returns

603883CN Consumer RetailingCN Market
7D-2.6%-4.8%0.4%
1Y15.9%79.0%55.5%

Return vs Industry: 603883 underperformed the CN Consumer Retailing industry which returned 79% over the past year.

Return vs Market: 603883 underperformed the CN Market which returned 55.5% over the past year.

Price Volatility

Is 603883's price volatile compared to industry and market?
603883 volatility
603883 Average Weekly Movement3.0%
Consumer Retailing Industry Average Movement4.0%
Market Average Movement5.2%
10% most volatile stocks in CN Market8.9%
10% least volatile stocks in CN Market3.0%

Stable Share Price: 603883 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 603883's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
200140,132Li Wangwww.lbxdrugs.com

LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network.

LBX Pharmacy Chain Joint Stock Company Fundamentals Summary

How do LBX Pharmacy Chain's earnings and revenue compare to its market cap?
603883 fundamental statistics
Market capCN¥12.72b
Earnings (TTM)CN¥414.22m
Revenue (TTM)CN¥22.19b
30.7x
P/E Ratio
0.6x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603883 income statement (TTM)
RevenueCN¥22.19b
Cost of RevenueCN¥14.97b
Gross ProfitCN¥7.22b
Other ExpensesCN¥6.80b
EarningsCN¥414.22m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

Sep 29, 2025

Earnings per share (EPS)0.54
Gross Margin32.53%
Net Profit Margin1.87%
Debt/Equity Ratio37.4%

How did 603883 perform over the long term?

See historical performance and comparison

Dividends

2.5%
Current Dividend Yield
15%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/23 16:50
End of Day Share Price 2025/09/23 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LBX Pharmacy Chain Joint Stock Company is covered by 19 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Qianyi LiChina International Capital Corporation Limited
Bing ZhaoChina Renaissance Securities
Zhu ChenCitic Securities Co., Ltd.